Presentation by Camille Lombard-Banek, NIST: Expending MAM Principles to the Characterization of Cell-based Therapies Presentation by Sarah Rogstad, FDA: Quality Considerations for MAM Leveraging the MAM to Improve Biotherapeutic Characterization, Rich Rogers
